According to GlobalData’s medical device pipeline database, four Continuous Renal Replacement Therapy Machines devices are in various stages of development globally. GlobalData’s report provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

All four devices of this category are in active stage of development. All devices are in the early stages of development.

Continuous Renal Replacement Therapy Machines are intended for dialysis treatment that is provided as a continuous 24 hour a day therapy. One unit consists of one continuous renal replacement therapy machine.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Continuous Renal Replacement Therapy Machines pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Continuous Renal Replacement Therapy Machines devices. Overall, most of these Continuous Renal Replacement Therapy Machines pipeline devices are being developed by private entities.

Key players involved in the active development of Continuous Renal Replacement Therapy Machines include Shandong Weigao Blood Purification Products and Baxter International.

For a complete picture of the developmental pipeline for Continuous Renal Replacement Therapy Machines devices, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.